Company Updates

Peppermint Appoints Australian Based Global Payments Expert

27th September 2016, ASX Announcement US Residential Fund (ASX: USR) is pleased to announce a distribution of 1.5 cents per stapled security for the quarter ended 30 September 2016. This distribution equates to an annualised yield of 11.3% at the security price at market close on 26 September 2016. In respect of the payment of […]

26th September 2016 Folkestone Maxim is pleased to announce that the Folkestone Maxim A-REIT Securities Fund has been added to the Asgard platform. Read more About Folkestone Maxim A-REIT Securities Fund The Folkestone Maxim A-REIT Securities Fund is a high conviction fund providing access to a diversified portfolio of quality ASX listed real estate securities which […]

26th September 2016 SuiteBox, the mobile office solution for professionals, has appointed Andy Marshall to lead its APAC sales efforts. Ian Dunbar, SuiteBox CEO, said: “I’m delighted to have Andy joining the SuiteBox team and heading up our sales efforts in Asia Pacific. Andy’s experience and insights into what advice customers really want, and how advisers can […]

26th September 2016, ASX Announcement OncoSil Medical Limited (ASX:OSL) (OncoSil Medical or the Company) a late stage medical company focused on localised treatments for subjects with pancreatic and liver cancer, is pleased to announce it has received a cash refund from the Australian Taxation Office of $2.3 million following the lodgement of the 2015/16 financial […]

26th September 2016, ASX Announcement Highlights BPS continues to execute its Bartercard growth strategy in North America, opening six new franchises across the US in a record-breaking month Bartercard now has a presence in eight states which represent 25% of US economic output BPS is continuing to pursue a robust pipeline of potential US franchises […]

21st September 2016, ASX Announcement MedAdvisor Limited (ASX: MDR, the Company) Australia’s leading digital medication adherence company are featured in CommSec’s Executive Series. Mr Robrt Read, CEO of MedAdvisor provides an update on the Company’s full year results, progress to date, its proposed acquisition of Healthnotes, and plans for growth in FY 2017. A selection […]

Welcome to the first monthly report for the MHOR Australian Small Cap Fund.  The fund got off to a positive start in its first month, outperforming the Small Ordinaries Benchmark by +4.52%. This comprised a +2.95% absolute positive return (our focus) against a market backdrop of -1.56%. We started the month with 100% cash and […]

23rd September 2016, ASX Announcement Chairmans Letter In the rapidly expanding MedAdvisor world there has been little time for reflection,; nonetheless, we critically measure our performance, our wins, and our also-rans but we rarely muse on the past. Our Annual Report forces you to do so. Our company has completed a transformative year – from […]